Navigation Links
Bottleneck: Similac infant formula off the Shelf

Nearly 300,000 bottles of Similac Infant Formula were off the shelf, after its manufacturer, the well-known Ross Products Division, recalled the product// following a suspected flaw in the bottle. No repercussions after the use of this product has been reported yet; however the company has decided to recall the product in order to rectify a mistake on the label regarding the Vitamin C content in the bottle.

Given below is a list of the formulas supplied to United States, Puerto Rico and Guam between May 8 and Sept. 5, which are being recalled. Similac Alimentum Advance liquid formula. Expiration date: May 1, 2007. Printed on the back of the bottle is the following stock code, 57512; and lot number, 401895V. Similac Advance with iron liquid. Expiration date: Nov. 1, 2007, stock code: 55961; and lot numbers: 40177RH and 40172RH. Similac Advance Hospital Discharge Kits. Stock code, 58986; and lot number, 41699DS.

A customer, who noticed an unusually dark color of the formula, brought the defect to the notice of the company. Apparently a key chemical in the bottle was missing, but which is crucial in preventing the break down of Vitamin C. Presently, this anomaly stands corrected, a spokeswoman of the company has confirmed.

The company has assured the Public that it will undertake to replace at no cost all products, which have been declared defective. Customers could access the following number for clarification: 800-624-3412.
'"/>




Page: 1

Related medicine news :

1. Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis!
2. Developmental, neurologic problems common in extremely preterm infants
3. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
4. CDC reveals relationship between prepregnant weight and heart defects in infants
5. Erythromycin and infants’ intestinal disorde
6. Radiofrequency catheter ablation safe for infants
7. Caffeine reduces infant blood flow
8. Risk of early neonatal death high in infants born in the night
9. Shorter infants have lower incomes in later life
10. Low Birth Weight infants could have Problems in the Future
11. Inhaled nitric oxide therapy does not reduce death risk of infants
Post Your Comments:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...and said that the euthanasia campaigner Dr Philip ... medicine in New Zealand. // The workshop informs ...eir lives. But the Council said that Dr Nitschke n...ctor to carry out his euthanasia workshops. On th...
...niversity researcher Chensheng "Alex" Lu, PhD, 'Or...wo common pesticides used in U.S. agricultural pro...ts of children with organic food items. The result...sticides was reduced to non-detectable levels. A...
... any cereal grain containing all its component par... have been flaked, rolled, cracked, ground or turn...o long as it is entire. // The Whole Grains Counci...e out with a stamp to make it easy for the public ...
...ic steroids, more specifically anabolic androgen s...on of sebaceous glands. Sebaceous glands present i...follicles and majority of the body surface. Anabo...swelling linked to allergy and to treat unwanted w...
Other Medicine News:
(Date:10/7/2008)...luates the efficacy of new device for detecting po...ng colonoscopy, ORLANDO, Fla., Oct. 7 /PRNewswire...nnual Scientific Meeting in Orlando (ACG 2008), re...nted results from a,multi-institutional clinical s...R) Retroscope(R), a new device that is designed to...
(Date:10/7/2008)...howed Larazotide Acetate Prevented Immunologic Cha... with Celiac Disease, Additional Data Indicates Po...RLANDO, Fla., Oct. 7 /- Alba Therapeu...al studies this week at the American,College of Ga...g. Data from,study CLIN 1001-004, the first Phase ...
(Date:10/7/2008)...- Data Presented Today at ACG Annual Scientific Me...all/ -- Ironwood,Pharmaceuticals, Inc. (formerly M...: FRX ) today announced the presentation of resul...afety and efficacy in 420 patients with,irritable ... of the data,indicates that once- daily oral dosin...
(Date:10/7/2008)...nt, Prospective Randomized Placebo-Controlled Phas...t Improved Overall Survival., MOUNTAIN VIEW, Cali...utics has now evaluated the mature Phase II data f...ate PROSTVAC(TM) that had been,obtained as part of...l,Cancer Institute (NCI) in the US., The results ...
Breaking Medicine Technology:National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Small Lifestyle Changes Can Boost Longevity 9208 1Small Lifestyle Changes Can Boost Longevity 9208 2Elekta Negotiates To Acquire CMS 2496 1Elekta Negotiates To Acquire CMS 2496 2Elekta Negotiates To Acquire CMS 2496 3Elekta Negotiates To Acquire CMS 2496 4Elekta Negotiates To Acquire CMS 2496 5Multiple skin cancer risk behaviors are common among US adults 9203 1Multiple skin cancer risk behaviors are common among US adults 9203 2Multiple skin cancer risk behaviors are common among US adults 9203 3William R Ringo Joins Hyperion Therapeutics Inc Board of Directors as Chairman 1160 1William R Ringo Joins Hyperion Therapeutics Inc Board of Directors as Chairman 1160 2
...007 - Today, President Bush,Signed An Executive Or...rch On Pluripotent Stem Cells. Scientists have rec...ursue the potential benefits,of pluripotent stem c...ential to develop into nearly all the cell types a... life in the process. By,expanding support for non...
...e 2 Diabetes Presented at the,67th Annual Scientif...FRANCISCO, June 25, 2007 /PRNewswire/ -- DiObex, I...cused on the development,of therapeutics to treat ...on of top line data of its phase 2a study of DIO-9...or for the treatment of,type 2 diabetes. , Results...
Other Medicine Technology:Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 2Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 3DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 2DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 3
...th EnCap technology is used for cardiac and great ...losure. It is glutaraldehyde-treated bovine perica...ty, plus improved suturability and handling over s...tch product is the ability to prevent calcificatio...
Unique triaxial catheter design and ergonomic handle for easy and accurate deployment. Six proprietary radiopaque Nitinol markers on the proximal and distal ends of the stent enhance visibility. Corr
Supreme and Response catheters comprise the world's broadest line of fixed-curve catheters available for electrophysiology procedures. Their advanced catheter design and materials technology provide
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety.
Medicine Products: